EROAD swings to a $144.2m net loss despite $28.7m EBITDA and stronger cash flow

This occurred despite EBITDAI holding broadly stable at $28.7m against $29.2m, and revenue growing 3.3% to $99.1m. Total equity fell from $311.8m to $186.8m and total assets from $443.8m to $316.7m, a reduction consistent in scale with the loss but not itemised in the disclosed release excerpts. Operating cash flow improved to $25.7m from $17.3m, and free cash flow to $6.2m referenced in commentary reconciled to $5.1m on a pre-lease basis in the financial statements, up from $0.1m.

This matters because it means the headline loss cannot yet be separated from underlying trading performance, so operating conclusions from EBITDA and revenue alone risk overstating how the business is actually performing. Second, cash conversion improved to 89.5% of EBITDA from 59.2%, but this was helped by a working-capital release of $29.7m (owed working capital fell to $3.5m from $33.2m) even as receivable days nearly doubled to 116 from 63. That combination suggests some of the cash strength is timing-related rather than a structural improvement in collections. Third, the equity base has been reduced by roughly $125m, which narrows the balance-sheet capacity available to fund the ANZ expansion strategy referenced in the release title.

The supplied historical shape shows the first half typically represents roughly 49% of full-year revenue and EBITDA, but the prior comparable first half already carried a disproportionately negative share of full-year NPAT, and this half is a much larger loss again, so there is no basis in the current data to project whether the second half offsets the scale of this loss. The absence of guidance limits any assessment of whether this is an isolated half or the start of a trend.

However, part of that cash improvement rests on a working-capital release rather than a structural change in collections, particularly given receivable days lengthened to 116 days. Capex also rose 36.3% to $12.4m, taking capex intensity to 12.5% of revenue from 9.5%, which increases investment demands on a now-smaller equity base. The pretax and net losses, by contrast, are not supported by any disclosed one-off item in the extraction, so their durability cannot be assessed from what has been provided.

This briefing cannot assess the true nature or recurrence risk of the charge driving the pretax and net losses because the supplied release excerpts do not itemise it.